STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

BOENNIGHEIM, Germany and LIGONIER, Ind., Nov. 4, 2025 /PRNewswire/ -- Hohenstein Medical – a division of Hohenstein Laboratories and a leading provider of testing, research and certification services ...

Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Biocompatibility Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives in healthcare ...

DUBLIN--(BUSINESS WIRE)--The "Biocompatibility Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives in healthcare face evolving ...

In the test, the chemicals leaching off of the device are compared with a searchable database that provides background on toxicity and the Cramer classification. The proposed change in the standard ...